Vontobel Holding Ltd. trimmed its position in Xylem Inc. (NYSE:XYL - Free Report) by 3.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 691,867 shares of the industrial products company's stock after selling 21,264 shares during the period. Vontobel Holding Ltd. owned approximately 0.28% of Xylem worth $89,500,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in Xylem by 1.3% in the first quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company's stock valued at $3,465,122,000 after acquiring an additional 362,127 shares in the last quarter. Swedbank AB boosted its stake in Xylem by 13.9% in the second quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company's stock valued at $564,906,000 after acquiring an additional 531,890 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Xylem by 7.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company's stock valued at $480,767,000 after acquiring an additional 274,123 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in Xylem by 689.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock valued at $443,074,000 after acquiring an additional 3,239,203 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in Xylem by 2.9% in the first quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company's stock valued at $401,743,000 after acquiring an additional 94,560 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the sale, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This trade represents a 25.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.27% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Several equities research analysts have recently commented on XYL shares. Mizuho lifted their price objective on shares of Xylem from $125.00 to $140.00 and gave the stock a "neutral" rating in a research note on Friday, September 12th. TD Cowen lifted their price objective on shares of Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a research note on Tuesday, August 26th. Stifel Nicolaus lifted their price objective on shares of Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Citigroup reiterated a "buy" rating and set a $152.00 price objective (up from $137.00) on shares of Xylem in a research note on Monday, July 14th. Finally, UBS Group raised their target price on shares of Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a report on Tuesday, August 5th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Xylem presently has an average rating of "Moderate Buy" and a consensus target price of $152.33.
Get Our Latest Report on Xylem
Xylem Stock Up 0.1%
XYL opened at $148.22 on Thursday. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $151.16. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90. The company has a fifty day moving average of $142.98 and a two-hundred day moving average of $130.02. The stock has a market capitalization of $36.08 billion, a price-to-earnings ratio of 38.50, a PEG ratio of 2.56 and a beta of 1.13.
Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The company had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.20 billion. During the same quarter in the previous year, the company earned $1.09 earnings per share. The firm's revenue for the quarter was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, research analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.
Xylem Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th were given a $0.40 dividend. The ex-dividend date was Thursday, August 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. Xylem's dividend payout ratio (DPR) is 41.56%.
Xylem Company Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report